Skip to main content

Table 4 Baseline characteristics of subjects by quartiles of LDL

From: The association between dyslipidemia and the incidence of chronic kidney disease in the general Zhejiang population: a retrospective study

LDL (mmol/l)

Q1(≤2.30)

(n = 1321)

Q2(> 2.30,  ≤ 2.80)

(n = 1292)

Q3(> 2.80,  ≤ 3.30)

(n = 1280)

Q4(> 3.30)

(n = 1290)

P

value

Age (Years)

40(19)

46(23)*

50(23)*#

54(18)*#※

< 0.001

Male (%)

745(56.4)

781(60.4)*

837(65.4)*#

813(63.0)*#※

< 0.001

BMI (kg/m2)

22.29 ± 2.93

23.01 ± 2.98*

23.59 ± 2.91*#

24.10 ± 2.98*#※

< 0.001

Overweight

(24 ≤ BMI < 28) (%)

318(24.1)

386(29.9)*

487(38.0)*#

540(41.9)*#※

< 0.001

Obesity (BMI ≥ 28) (%)

49(3.7)

61(4.7)*

84(6.6)*#

117(9.1)*#※

< 0.001

SBP (mmHg)

121.53 ± 18.07

123.60 ± 17.72*

126.75 ± 18.62*#

130.13 ± 19.13*#※

< 0.001

DBP (mmHg)

73.26 ± 11.35

74.38 ± 11.00*

76.52 ± 11.34*#

78.11 ± 10.95*#※

< 0.001

TC (mmol/L)

3.91 ± 0.58

4.51 ± 0.45*

5.01 ± 0.42*#

5.92 ± 0.71*#※

< 0.001

TG (mmol/L)

1.35 ± 1.40

1.35 ± 0.96

1.43 ± 0.80*#

1.59 ± 0.78*#※

< 0.001

HDL-C (mmol/L)

1.31 ± 0.34

1.30 ± 0.32

1.28 ± 0.29*

1.29 ± 0.26*

0.065

BUN (mmol/L)

4.81 ± 1.11

4.96 ± 1.14*

5.03 ± 1.14*#

5.20 ± 1.13*#※

< 0.001

FPG (mmol/L)

5.12 ± 0.81

5.17 ± 0.73*

5.28 ± 0.85*#

5.38 ± 0.89*#※

< 0.001

SCr (μmol/L)

80.73 ± 13.83

82.56 ± 13.73*

83.82 ± 13.63*#

84.11 ± 13.41*#

< 0.001

SUA (mg/dl)

5.35 ± 1.33

5.54 ± 1.31*

5.69 ± 1.34*#

5.90 ± 1.35*#※

< 0.001

Hypertension (%)

164(12.4)

190(14.7)*

209(16.3)*#

286(22.2)*#※

< 0.001

Diabetes (%)

44(3.3)

40(3.1)

57(4.5)*#

57(4.4)*#

0.147

eGFR (ml/min/1.73m2)

90.39 ± 16.53

87.05 ± 15.37*

85.29 ± 14.53*#

82.06 ± 13.37*#※

< 0.001

New incident CKD (%)

49(3.7)

49(3.8)

42(3.3)*#

87(6.7)*#※

< 0.001

  1. *Compared with Q1 group, P < 0.05. #Compared with Q2 group, P < 0.05. Compared with Q3 group, P < 0.05